INS and autoimmune thyroid disease: Certainly, it cannot be excluded that other insulin-sensitizing agents, such as dipetidyl peptidase-4 inhibitors, glucagon-like peptide-1 agonists, and thiazolidinediones, administered in monotherapy or in combination with metformin, are superior to metformin alone in patients with autoimmune thyroiditis.